Among patients with cryptococcal meningitis who did not have AIDS, the administration of amphotericin B combined with flucytosine over a period of four to six weeks led to success rates of 75 to 85 percent.4 , 5 This regimen has been less effective among patients with AIDS, in whom success rates with amphotericin B (0.3 to 0.5 mg per kilogram of body weight per day) with or without flucytosine are only 40 to 50 percent and drug intolerance is common, especially when flucytosine is used.1 , 5 6 7 8 9 By contrast, Larsen et al. reported success in all six patients treated with higher doses of amphotericin B (0.7 mg per kilogram per day for the first two weeks of therapy) plus flucytosine.10 However, even among patients successfully treated, high relapse rates necessitate the use of long-term maintenance therapy.1 , 6 7 8 , 11